Is NXY-059 an advancement in the treatment of acute ischaemic stroke?
Doggrell
Sheila A
SA
School of Science, Charles Darwin University, PO Box 41246, Casuarina, Northern Territory, 0811, Australia. sheila.doggrell@cdu.edu.au
D000208:Acute Disease; D000818:Animals; D001557:Benzenesulfonates / Q000737:chemistry / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000188:drug therapy* / Q000453:epidemiology; D002317:Cardiovascular Agents / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D009589:Nitrogen Oxides / Q000737:chemistry / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology
D001557:Benzenesulfonates; D002317:Cardiovascular Agents; D009589:Nitrogen Oxides; C120851:disufenton sodium